| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1718201A Medicine used for tonifying-kidney strengthening-yang and replenishing-qi to invigorate the spleen, and its prepn. method |
| 01/11/2006 | CN1718188A Terazosin hydrochloride dripping pills, and its prepn. method |
| 01/11/2006 | CN1235875C Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 01/11/2006 | CN1235637C Methods for treating diabetes |
| 01/11/2006 | CN1235634C Chinese medicine powder for treating gallstones and preparation method thereof |
| 01/11/2006 | CN1235629C Traditional Chinese medicine composition for treating choleithiasis |
| 01/11/2006 | CN1235628C Lithagogue decoction |
| 01/11/2006 | CN1235621C Medicine composition for treating prostate proliferation, and its prepn. method |
| 01/11/2006 | CN1235608C Medicine for curing prostatitis, hyperplasia of prostate and urinary infection and its preparation method |
| 01/11/2006 | CN1235594C Cell growth regulating factor Q and its prepn process |
| 01/11/2006 | CN1235590C Phenasteroid gel preparation |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | CA2373395C Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
| 01/05/2006 | US20060004106 For urogenital disorders; improved side effect reduction, bioavailability, pharmacokinetics and half-life; N,N-diisopropyl-3-(2-methoxy-5-trifluoromethylphenyl)-3-phenylpropanamine |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 01/05/2006 | US20060004078 N-hydroxyformamidine derivatives |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004075 Substituted aryl amides as IP antagonists |
| 01/05/2006 | US20060004051 Compounds |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
| 01/05/2006 | US20060003992 New drug combinations |
| 01/05/2006 | US20060003988 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
| 01/05/2006 | US20060003379 Smad6 and uses thereof |
| 01/05/2006 | CA2570813A1 Lactam tachykinin receptor antagonists |
| 01/04/2006 | EP1612215A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/04/2006 | EP1612208A2 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/04/2006 | EP1612203A1 Crystalline forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 01/04/2006 | EP1611130A2 Reverse-turn mimetics and method relating thereto |
| 01/04/2006 | EP1610778A2 Treatment of benign prostatic hyperplasia |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1044008B1 Use of aliphatic polyamines for reducing oxalate |
| 01/04/2006 | EP0977562B1 Methods and compositions for delivery of taxanes |
| 01/04/2006 | CN1717408A Carbamic acid esters with anticholinergic activity |
| 01/04/2006 | CN1717252A Preparation containing basic drug |
| 01/04/2006 | CN1717230A Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor |
| 01/04/2006 | CN1715290A Dengxin subergorgia saponin |
| 01/04/2006 | CN1714843A Health medicinal wine for nourishing kidney |
| 01/04/2006 | CN1714811A Radix bupleuri dripping pill and its preparing method |
| 01/04/2006 | CN1714790A Fibrauretine transfusion preparation and its preparing method |
| 01/04/2006 | CN1714783A Implantable particles for tissue bulking and the treatment |
| 01/04/2006 | CN1234711C Mikanolide derivatives,their preparation and its therapeutic uses |
| 01/04/2006 | CN1234708C Novel imidazotriazinones and the use thereof |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234679C Shortened synthesis of 3, 3-diaryl propylamine derivatives |
| 01/04/2006 | CN1234414C Drugs for complications of diabetes and neuropathy and utilization thereof |
| 01/04/2006 | CN1234407C Medicine for treating chronic prostatitis and its preparing method |
| 01/04/2006 | CN1234396C Medicine for treating persistent recurrent non-gonococcal urethritis and its preparing method |
| 01/04/2006 | CN1234377C Pure Chinese traditional medicine tablet for treating prostate proliferation of blood stasis blocking the bladder syndrome |
| 01/04/2006 | CN1234367C Arylazo-substituted imidazole for treatment of stress urinary incontinence |
| 01/04/2006 | CN1234357C Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/04/2006 | CN1234351C Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982266 N-(4-indol-5-yloxyphenyl){4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}carboxamide for example; antiproliferative agents which inhibit phosphorylation of kinases such as tyrosine kinase; cancer, arteriosclerosis |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982261 A progesterone receptor antagonist for providing progestational therapy, treating cancer of breast, uterine, ovarian, endometrial, or prostate, providing contraceptives, hormone replacement therapy |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | US6982258 Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 12/29/2005 | WO2005060939A3 Controlled-release pharmaceutical formulation |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288366 Administering N-(4-carboxybutyl)-N-(p-carboxybenzyl)-benzyl- or phenethyl-amine derivatives: 4-({(4-Carboxybutyl)[3-(4-cyclohexylphenoxy)benzyl]amino}methyl)-benzoic acid; stimulate soluble guanylate cyclase also via a novel mechanism of action which takes place without involvement of the heme group |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288325 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288297 {4-[6-methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl]piperazinyl}-N-[4-(methylethoxy)phenyl]carboxamide; inhibits phosphorylation of platelet-derived growth factor receptor to hinder abnormal cell growth/wandering; cancer; arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis |
| 12/29/2005 | US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/29/2005 | US20050288219 Osteoprotegerin in milk |
| 12/29/2005 | US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/29/2005 | US20050287160 Useful for treatment and prevention of prostate cancer, especially when associated with bone metastases; also a cytotoxic T lymphocyte that specifically recognizes complex of HLA-A24 antigen and the cancer antigen peptide |
| 12/28/2005 | EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2005 | EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/28/2005 | EP1609504A1 T-type calcium channel blockers |
| 12/28/2005 | EP1609475A1 Remedy or preventive for low turnover bone diseases |
| 12/28/2005 | EP1609468A2 A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis |
| 12/28/2005 | EP1497288B1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament |
| 12/28/2005 | EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES |
| 12/28/2005 | EP1377593B1 2-amino-propanol derivatives |
| 12/28/2005 | EP1368023B1 Utilization of buprenorphine in urinary incontinence therapy |
| 12/28/2005 | EP1326597B1 Use of kcnq potassium channel agonists for the manufacture of a medicament for modulating bladder function |
| 12/28/2005 | EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method |
| 12/28/2005 | EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |